Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (9602)	11/29/2003 2:18:06 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 52153

>> and down by shady shorters << What makes you believe that the shorters, in legitimate scams (:-)), aren't also the pumpers? In some instances, outright criminal activity by individuals who would acknowledge that they're criminals?? It is TO THEIR ADVANTAGE that share price be maintained. It makes most sense if the pumpers and shorters are the same individuals...... each short sale would bring in more bucks. The game before 9/11 was to play long, to issue a bazillion shares and to pump a piece of scam crap. Refer to Bio-Flourescent Technologies, if you like. The game after 9/11 was to whore down stocks, good or bad. The whores realized that, long, they needed to find sellers. Naked shorting, however? If the company never regained footing, there would never be a need to cover. Every cent derived from the short sale would be profit. aegis.com I don't know what the all-time high was, but I remember once calculating the market cap at $280M. This particular group had at least two of these babies running at once, each secured by a single rental property in San Diego.

To: Biomaven who wrote (9602)	12/3/2003 6:32:54 PM
From: Madharry	Read Replies (1) \| Respond to of 52153

Its interesting to me that there has not been one comment on this thread about the effect of the merck deal on the shares of neurogen. in the premarket after the deal was announced the stock was about 8.60 a +2 increase, the high was 11.80 or so and the close was around 10.70. today the stock closed at 8.95 after being as low as 8.60. Does anyone here have any thoughts as to how much added value to the market cap the merck deal should bring? I felt the way i look at things the immediate impact was in the $60MM- $100MM range and this not taking into account the added value of Merck respecting the technology enough to buy into it. As a result i currently own a full position in Neurogen.